The New York Times: Drug Coupons: Helping a Few at the Expense of Everyone
October 12, 2016
A research team from Harvard, Northwestern and the University of California, Los Angeles, looked at brand-name drugs that also had...
Drug Benefit Solutions is an educational platform explaining how pharmacy benefit managers (PBMs) reduce costs and improve quality on prescription drug benefits for consumers, employers, unions, and government programs.
Drug Benefit Solutions is a project of the Pharmaceutical Care Management Association (PCMA).
The New York Times: Drug Coupons: Helping a Few at the Expense of Everyone
October 12, 2016
A research team from Harvard, Northwestern and the University of California, Los Angeles, looked at brand-name drugs that also had...
Forbes: Mylan’s EpiPen Price ‘Cut’ An Outdated Drug Industry PR Move
August 28, 2016
It’s not surprising that EpiPen maker Mylan would defend its 400% price increase with the line that it’s okay because...
Market Watch: Mylan offers price plan to help patients but its programs are still short on details
August 26, 2016
Pharmaceutical companies have not routinely fully disclosed how these patient assistance programs work and are funded in their financial statement...
Pittsburgh Post-Gazette: Mylan offers new discounts for its EpiPen
August 25, 2016
Outrage over escalating prices for Mylan’s EpiPen forced the company to react Thursday, as lawmakers demanded relief for parents with...
Pittsburgh Tribune-Review: Mylan to expand discount programs as EpiPen prices spike
August 25, 2016
“It’s not credible to assert that Mylan’s price hikes are the fault of those paying the bills: namely the employers,...
CNN: EpiPen CEO: Blame the ‘broken’ system, not me
August 25, 2016
Mylan was forced to respond to the national outrage over a more than 400% increase in price for the lifesaving allergy...
USA Today: PCMA President Mark Merritt Shines Light on Drug Manufacturer Copay Coupon Programs
June 08, 2016
Charity-run funds to help patients pay high co-payments face new scrutiny by prosecutors in two states and increased federal oversight,...
Pharmaceutical Commerce: PCMA President Mark Merritt Discusses Drug Prices, other Key Issues
May 10, 2016
As befits the sizable part of the US economy that healthcare represents, its major sectors—hospital providers, insurers, medical professional societies...